Literature DB >> 3258373

Lymphocytic gastritis--relationship to Campylobacter pylori infection.

M F Dixon1, J I Wyatt, D A Burke, B J Rathbone.   

Abstract

The existence of a distinctive form of chronic gastritis characterized by marked infiltration of the surface and pitlining epithelium by mature T lymphocytes has been confirmed. Seventeen cases were identified amongst 382 patients with active chronic gastritis (4.5 per cent). The cases with lymphocytic gastritis had significantly higher counts of intraepithelial lymphocytes than sex and age-matched controls drawn from a series of patients with the usual form of active Type B chronic gastritis. Furthermore, the lymphocytic gastritis group exhibited unusual endoscopic findings, namely erosions and 'raised lesions', in the body of the stomach. Such appearances have been previously described as 'varioliform' gastritis. Only seven of the patients (41 per cent) had C. pylori-positive biopsies, compared with over 90 per cent in the generality of active chronic gastritis, but all but two of the eleven cases tested had serological evidence of C. pylori infection. While the pathogenesis of this condition is unclear, the histological resemblance to coeliac disease suggests that lymphocytic gastritis might also represent an abnormal response to a local antigen to which the patient has become sensitized. It is possible that this antigen is C. pylori.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3258373     DOI: 10.1002/path.1711540204

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  38 in total

Review 1.  Primary gastric T-cell lymphoma accompanied by HTLV-I, HBV and H. pylori infection.

Authors:  T Itatsu; H Miwa; R Ohkura; R Iwazaki; H Oide; T Murai; M Nakajima; S Watanabe; S Hirai; M Otaka; N Sato
Journal:  Dig Dis Sci       Date:  1999-09       Impact factor: 3.199

2.  Helicobacter pylori-associated protein-losing hypertrophic gastropathy with hypercholesterolemia.

Authors:  A N Kapsoritakis; S Potamianos; E Matrella; S Koukouraki; E Oeconomaki; M Tzardi; N Karkavitsas; E A Kouroumalis
Journal:  Dig Dis Sci       Date:  1999-09       Impact factor: 3.199

3.  Lymphocytic gastritis and coeliac disease.

Authors:  T Karttunen; S Niemelä
Journal:  J Clin Pathol       Date:  1990-05       Impact factor: 3.411

4.  Hypertrophic gastropathy with gastric adenocarcinoma: Menetrier's disease and lymphocytic gastritis?

Authors:  J F Mosnier; J F Flejou; G Amouyal; B Gayet; G Molas; D Henin; F Potet
Journal:  Gut       Date:  1991-12       Impact factor: 23.059

5.  Lymphocytic gastritis, gastric adenocarcinoma, and primary gastric lymphoma.

Authors:  A P Griffiths; J Wyatt; A S Jack; M F Dixon
Journal:  J Clin Pathol       Date:  1994-12       Impact factor: 3.411

6.  Serological diagnosis of Helicobacter pylori--evaluation of four tests in the presence or absence of non-steroidal anti-inflammatory drugs.

Authors:  A S Taha; J Reid; P Boothmann; C G Gemmell; F D Lee; R D Sturrock; R I Russell
Journal:  Gut       Date:  1993-04       Impact factor: 23.059

7.  Local cellular and immune response by antral mucosa in patients undergoing treatment for eradication of Helicobacter pylori.

Authors:  K Jaskiewicz; J A Louw; I N Marks
Journal:  Dig Dis Sci       Date:  1993-05       Impact factor: 3.199

8.  Chemical gastritis and Helicobacter pylori related gastritis in patients receiving non-steroidal anti-inflammatory drugs: comparison and correlation with peptic ulceration.

Authors:  A S Taha; I Nakshabendi; F D Lee; R D Sturrock; R I Russell
Journal:  J Clin Pathol       Date:  1992-02       Impact factor: 3.411

9.  Duodenal histology, ulceration, and Helicobacter pylori in the presence or absence of non-steroidal anti-inflammatory drugs.

Authors:  A S Taha; S Dahill; I Nakshabendi; F D Lee; R D Sturrock; R I Russell
Journal:  Gut       Date:  1993-09       Impact factor: 23.059

10.  Epithelial cell proliferation and glandular atrophy in lymphocytic gastritis: effect of H pylori treatment.

Authors:  Johanna M Mäkinen; Seppo Niemelä; Tuomo Kerola; Juhani Lehtola; Tuomo J Karttunen
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.